No takes yet. Share an insight, caveat, or question.
Preclinical study demonstrates targeted tumor uptake and cytotoxicity with high-molar-activity samarium-153 in tumor models, highlighting mass separation for targeted radiotherapy.
Vermeulen et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: